SpineThera Announces Addition of Vice President of Global Clinical Operations to Management Team

MEDICAL ALLEY, MINNESOTA, UNITED STATES, September 27, 2021 /EINPresswire.com/ — SpineThera, Inc., a privately held, clinical stage pharmaceutical company focused on the development of SX600 (a novel formulation of sustained-release dexamethasone for treatment of sciatica) announced today that Vicki Gashwiler has joined the company as the Vice President of Global Clinical Operations.

Jeff Missling, Chief Executive Officer of SpineThera stated “Vicki is a strong addition to our management team. With over 20 years in both healthcare and clinical research, she brings the knowledge and experience that SpineThera needs as we look to our future global clinical development objectives. Those objectives will leverage SpineThera’s micro-suspension platform, which is designed to provide superior injectability of high-concentration, sustained-release drug formulations and to enable development of new drugs for unmet medical needs. We continue to study our lead drug product candidate for lumbar radiculopathy, SX600, in the SALIENT trial in Australia.”

Vicki Gashwiler is a skilled clinical research professional with extensive experience in clinical trial management. Having worked as a Registered Nurse and as a Coordinator at a clinical research site, she has a clear understanding of patient care pathways and how clinical trials can maximize their effectiveness, enrollment and compliance. She previously worked both on the sponsor side and at multiple, varied size Contract Research Organizations. Most recently, Vicki served as an Executive Director at a mid-sized CRO, managing a diverse team of clinical trial professionals. Vicki has almost 10 years of project management experience and has managed large global clinical teams, executing trials around the world. She stated “I am excited to join the SpineThera team and play a key role in our global clinical development efforts leveraging our injectable, sustained-release drug delivery platform technology.”

About SpineThera
SpineThera is a clinical stage pharmaceutical company working to improve the lives of patients by creating injectable drugs utilizing its proprietary and differentiated sustained-release platform technology. Our goal is to develop proprietary drugs that offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs. The company’s lead investigational drug product, SX600, is a novel formulation of dexamethasone being developed for lumbar radiculopathy. SpineThera, Inc., is based is Medical Alley, Minnesota, the global epicenter of health innovation and care. SpineThera Australia Pty Ltd is a wholly owned subsidiary of SpineThera, Inc., and is the sponsor of the SALIENT study.

Press Contact
Jeff Missling | jmissling@spinethera.com

Jeff Missling
SpineThera, Inc.
jmissling@spinethera.com


Source: EIN Presswire

X-Ray Detector Market Size to reach $8.87 Billion and Registering a CAGR of 6.4% by 2027

X-Ray  Detector Market

X-Ray Detector Market

Increase in demand for digital imaging technologies, advantages offered by digital X-ray detectors, and favorable reimbursement policy for X-rays major factors

X-ray is a form of electromagnetic radiation high energy & can pass through most objects, including body. Among many applications of X-rays such as veterinary, medical, dental, industrial and security”

— Allied Market Research

PORTLAND, OR, UNITED STATES, September 27, 2021 /EINPresswire.com/ — Increase in demand for digital imaging technologies, advantages offered by digital X-ray detectors, and favorable reimbursement policy for X-rays are the major factors that propel the growth of the global X-ray detector market. Nevertheless, high cost associated with digital X-ray detectors impedes the market growth. However, increase in demand for wireless X-ray detectors and growth in medical tourism in developing countries are anticipated to usher new opportunities in the near future.

"X-Ray Detector Market by Type (Flat Panel Detectors (FPDs), Charge-Coupled Device Detectors (CCDs), Line scan detector, and Computed Radiography Plates/Cassettes) and Application (Medical, Veterinary, Security, Dental, and Industrial): Global Opportunity Analysis and Industry Forecast, 2020–2027" According to the report published by Allied Market Research, the global X-ray detector market garnered $5.12 billion in 2019, and is projected to reach $8.87 billion by 2027, registering a CAGR of 6.4% from 2020 to 2027.

Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/1528

Covid-19 Scenario:

• The investments for diagnostic X-ray systems have been increased to enable the diagnostic imaging facilities during covid-19.

• The mobile digital radiography (DR) systems are getting utilized for initial screening for pneumonia and secondary and progressive stages of covid-19.

• Moreover, the market has been through increased demand and is anticipated to witness a positive growth throughout.

The flat panel detector (FPDs) segment is anticipated to dominate the market by 2027-

Based on type, the flat panel detector (FPDs) segment contributed to the largest market share in 2019, accounting for more than four-fifths of the global X-ray detector market, and is projected to maintain its lead status during the forecast period. This is owing to high demand of FPDs and various advantages that it offers such as excellent image quality and ability to retrofit into existing X-ray tables. However, the computed radiography plates/cassettes segment is estimated to manifest the highest CAGR of 8.7% from 2020 to 2027. This is attributed to the fact that CR plates/cassettes are less expensive and not as risky to handle as FPDs. In addition, more availability of mechanical parts, less cost of maintenance, reusability for many times, and high demand of cost-effective X-ray procedures with better efficiency further boosts growth of the segment.

The medical segment held the lion's share in 2019-

Based on application, the medical segment accounted for the highest market share, contributing to nearly half of the global X-ray detector market in 2019, and is expected to maintain its dominant share by 2027. This is attributed to huge demand of X-ray procedures, increase in prevalence of chronic diseases, rise in geriatric population, and surge in adoption of digital imaging techniques in medical field. However, the veterinary segment is anticipated to grow at the highest CAGR of 8.2% during the forecast period. This is owing to rise in adoption of pets, increase in animal health expenditure, and growth in adoption of radiography in veterinary practices.

North America region would lead the trail by 2027-

Based on region, the North America region held the largest share of the global X-ray detector market, contributing to nearly half of the total share in 2019, and will continue its leadership position during the forecast period. This is attributed to the factors such as presence of key players that offer popular X-ray detectors in the region, well-established healthcare facilities, growth in number of medical imaging procedures, favorable reimbursement policies, rise in threats of terrorism, large focus on product quality & non-destructive testing, and growth in adoption of pets & animal farming. On the other hand, the Asia-Pacific region is anticipated to manifest the fastest CAGR of 8.4% from 2020 to 2027. This is owing to increase in healthcare expenditure, growth in medical tourism, rise in adoption of technologically advanced X-ray imaging products, presence of large geriatric population, and focus on skill development in the region.

Inquiry for Buying Reports@ https://www.alliedmarketresearch.com/purchase-enquiry/1528

Leading players of the market-

• Agfa-Gevaert N.V.
• Analogic Corporation (Altaris Capital Partners, LLC)
• Canon, Inc.
• Carestream Health, Inc.
• Comet Holding (YXLON International GmbH)
• Detection Technology Plc.
• Fujifilm Holdings Corporation (Fujifilm Medical Systems)
• General Electric
• Konica Minolta Holdings Inc.
• Koninklijke Philips N.V.
• Siemens AG
• Teledyne Technologies Incorporated (Teledyne DALSA, Inc.)
• Thales Group (Trixell)
• Varex Imaging Corporation.

Trending Reports of Healthcare:

Self-Monitoring Blood Glucose Strips Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

Infection Prevention & Enteral Access Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Topical Pain Relief Market Size to Reach $12.2 Billion and Growing at 5.2% CAGR By 2027

Topical Pain Relief

Topical Pain Relief

Rise in prevalence of arthritis, high demand from athletes, and lesser side effects as compared to conventional oral medicines would facilitate the growth

The COVID-19 pandemic has stressed healthcare systems of the world. A huge number of clinics and pain services have undergone a decline in number of patient visits during COVID-19”

— Allied Market Research

PORTLAND, OR, UNITED STATES, September 27, 2021 /EINPresswire.com/ — The growth of the topical pain relief market include increase in prevalence of arthritis, diabetic neuropathy, and other bone disorders across the globe, rise in geriatric population, fewer side effects caused by topical pain relief as compared to oral medications, and high adoption of topical pain relief products by sportsperson. However, topical pain relief medications can cause irritation, and these products are usually characterized by an unpleasant odor which impede the market growth. Conversely, the development of an online platform for topical therapeutics and the untapped market potential in emerging economies are expected to provide lucrative growth opportunities for the market.

“Topical Pain Relief Market by Therapeutic class, Formulation, Type and Distribution channel: Opportunity Analysis and Industry Forecast, 2020–2027," the global topical pain relief market size was valued at $8,864.0 million in 2019 and is expected to reach $12,219.7 million by 2027, registering a CAGR of 5.2% from 2020 to 2027

Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/4663

Topical pain relief medications are pain killers that are directly applied, rubbed, or sprayed on the skin over painful muscles or joints. They are designed to relieve pain as they are composed of different ingredients such as opioids, nonsteroidal anti-inflammatory drugs (NSAIDS), salicylates, capsaicin, and others. These products have a heating or cooling effect that stimulate the nerves near the pain point and relieve pain.

Covid-19 scenario:

• Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production.

• However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

• The report offers a detailed segmentation of the topical pain relief market based on therapeutic class, type, distribution channel, and region form.

On the basis of therapeutic class, the market is segmented into non-opioids and opioids. The non-opioids segment is further divided into no steroidal anti-inflammatory drugs (NSAIDS), methyl salicylate, capsaicin, lidocaine, and other non-opioids. The opioids segment is further bifurcated into buprenorphine and fentanyl. Non-opioids segment accounted for the largest topical pain relief market share in 2017, and is expected to continue this trend throughout the forecast period owing to high prefer ability and availability of non-opioids drugs.

By type, the topical pain relief market is segmented into prescription pain relief and over-the-counter (OTC) relief. Over-the-counter pain relief segment accounted for the largest market share in 2017 due to easy availability and high demand of topical pain relief products by sportsperson. Based on the formulation, the market is classified into cream, gel, spray, patch, and others. Cream based pain relief
Segment accounted for the largest market share in 2017 owing to high availability of these products with high success rate and lesser side effects. On the other hand, patch pain relief segment is expected to grow at a CAGR of 9.0% during the forecast period.

The leading market players analyzed in the report include Johnson & Johnson, GlaxoSmithKline Plc., Novartis AG, Reckitt Benckiser Group Plc., Pfizer Inc., Topical BioMedics, Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., AdvaCarePharma, and Nestle S.A. These players have implemented different strategies including partnerships, expansions, mergers & acquisitions, joint ventures, collaborations, and others to gain a strong position in the industry.

Inquiry for Buying Reports@ https://www.alliedmarketresearch.com/purchase-enquiry/4663

Key Market Segments:

By Therapeutic Class
• Non-opioids
o Nonsteroidal anti-inflammatory drug (NSAIDS)
o Methyl Salicylate
o Capsaicin
o Lidocaine
o Other Non-opioids
• Opioids
o Buprenorphine
o Fentanyl

By Formulation
• Cream
• Gel
• Spray
• Patch
• Others

By Type
• Prescription Pain Relief
• Over-the-counter (OTC) Pain Relief

By Distribution Channel
• Pharmacy & Drug Store
• e-Commerce
• Retail & Grocery Store

By Region:-
• North America
• Europe
• Asia-Pacific
• LAMEA

Similar Reports:

Alzheimer’s Therapeutics Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

Therapeutic Respiratory Devices Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Women Hypoactive Sexual Desire Disorder (HSDD) Treatment Market LATAM to Reach Valuation of $170 million by 2027

women Hypoactive Sexual Desire Disorder Treatment

Demand for hyposexual desire disorder treatments is on the rise, owing to surge in prevalence of lifestyle ailments such as stress and depression.

PORTLAND, OR, UNITED STATES, September 27, 2021 /EINPresswire.com/ — Hypoactive sexual desire disorder (HSDD) is the most prevalent sexual disorder among women of all ages, however it is also one of the most challenging disorders to address. It is the most common type of sexual dysfunction that occurs in women. HSDD is mainly associated with hyper function inhibition and hypo functional excitation regulated by neuromodulators in the brain. In addition, several physical conditions are also related to HSDD, which include anxiety, depression, diabetes, urinary incontinence, and multiple sclerosis. Its treatment includes psychotherapy or pharmacotherapy. Psychotherapy utilizes cognitive behavioral therapy, which offers counseling sessions with a sex therapist, whereas pharmacotherapy comprises treatment with numerous drugs, namely buspirone, bremelanotide, bupropion, flibanserin, and others.

The LATAM women hypoactive sexual desire disorder treatment market size accounted for $131 million in 2019, and is expected to reach $170 million by 2027, registering a CAGR of 3.8% from 2020 to 2027.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/7952

COVID-19 Impact Analysis on LATAM Hypoactive Sexual Desire Disorder (HSDD) Treatment Market

Lockdowns had an adverse impact on every type of business in Latin America. For instance, non-essential businesses such as retail business that operate with a physical location with access to public were closed. Furthermore, non-essential construction was also halted, recreational and entertainment businesses such as gyms, movie theaters, art centers, race tracks, salon, and public & private social clubs were also closed under the lock downs. However, essential businesses such as grocery stores, chemist stores, hospitals, veterinary hospitals remained functional during lockdowns. Furthermore, the impact of COVID-19 on LATAM women hypoactive sexual desire disorder treatment market was fairly negative, owing to fall in demand and supply of drugs used in treatment. Furthermore, other factors that were responsible for a negative impact on the market included limited availability of medical care, shortage of healthcare staff, and rise in burden of COVID-19 related hospitalization. However, various governments are working toward ensuring undisrupted supply of drugs, which is expected to lead to a stabilization in the market overtime.

The LATAM women hypoactive sexual desire disorder (HSDD) treatment market is expected to experience significant growth during the forecast period, owing to rise in prevalence of lifestyle ailments, such as stress, depression, anxiety, prolonged fatigue, and rise in use of medicines that induce a state of hypoactive sexual desire disorder. In addition, rise in number of surgical procedures that lead to sexual dysfunction are also expected to boost the growth of LATAM women hypoactive sexual desire disorder treatment market during the forecast period. However, lack in awareness related to hypoactive sexual desire disorder are anticipated to hamper the market growth during the forecast period. Presence of strong pipeline products which present in late phases of clinical trials are expected to get approved for commercialization in the coming years. Hence, the presence of pipeline drugs offers a lucrative opportunity for the LATAM women hypoactive sexual desire disorder treatment market.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/7952

The LATAM women hypoactive sexual desire disorder (HSDD) treatment market is segmented on the basis of type, sales channel, and country. By type, the market is categorized into buspirone and bupropion. On the basis of sales channels, it is divided into hospitals, clinics and online retailers. Country wise, it is classified into Brazil, Argentina, Chile, Colombia, Ecuador, Peru, and Rest of the LATAM.

By type, the LATAM hypoactive sexual desire disorder treatment market is segmented into buspirone and bupropion. The buspirone segment is expected to exhibit fastest growth rate during the forecast period, owing to the fact that it is FDA approved treatment aimed at HSDD in premenopausal women, which makes it a preferred brand over the off label treatments. Furthermore, this treatment type has lesser side effects as compared to other treatment options present in the market.

Country wise, Argentina is expected to exhibit the fastest growth during the forecast period. This is attributed to factors such as rise in healthcare infrastructure, surge in healthcare expenditure, and rise in awareness related to hypoactive sexual desire disorder.

Access Full Report @ https://www.alliedmarketresearch.com/latam-hypoactive-sexual-desire-disorder-treatment-market-A07587

The Major Key Players Are:

Aurobindo Pharma, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Mylan N.V., Novartis AG, Palatin Technologies, Inc., Sprout Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and Zydus Cadila.

Key Findings Of The Study:

• By treatment type, in terms of value, the bupropion segment dominated the market in 2019, and is anticipated to maintain its dominance throughout the forecast period
• By sales channel, the clinics segment is anticipated to grow with the highest CAGR throughout the forecast period.
• By treatment type, the bupropion segment accounted for more than half the share of the market in 2019.
• By country, Argentina is anticipated to grow at the highest rate during the analysis period.

Trending Reports In Healthcare Industry:

Diagnostic Electrocardiograph (ECG) Market Analysis, Industry Forecast 2030

Digital Impression Systems Market Analysis, Industry Forecast, 2030

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Industry Forecast, 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Sleep Apnea Diagnostics Market Size Expected to Reach $168 Million and Growing at a CAGR of 6.8% by 2025

Sleep Apnea Diagnostics Market

Sleep Apnea Diagnostics Market

Technological advancements pertaining to the development of home care diagnostic devices by the leading manufacturers further boost the growth of the market.

Symptoms of sleep apnea include daytime sleepiness, loud snoring, and restless sleep. Approximately 18 million Americans suffer from sleep apnea, while only 20% have been diagnosed and treated”

— Allied Market Research

PORTLAND, OR, UNITED STATES, September 27, 2021 /EINPresswire.com/ — “Sleep Apnea Diagnostics Market by Product (Polysomnography (PSG) Device, Actigraphy System, Respiratory Polygraph, Sleep Apnea Screening Device, and Oximeter) and End User (Hospitals & Sleep Laboratories and Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2018 – 2025.” According to the report, the global sleep apnea diagnostics market was estimated at $99 million by 2017 and is expected to garner $168 million by 2015, growing at a CAGR of 6.8% from 2018 to 2025.

Rise in prevalence of obesity across the globe, increase in number of employees working in shifts as well as under stressful work conditions and technological advancements in sleep apnea diagnostic devices have driven the growth of the market. On the other hand, high cost associated with the sleep apnea diagnostic devices and lack of awareness among patients regarding sleep apnea have happened to restrain the growth to some extent. Nevertheless, emerging markets in developing economies have created a number of opportunities in the sector.

Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/4666

The sleep apnea diagnostics market is growing at a significant pace due to surge in incidence of sleep apnea across the globe. Further, leading manufacturers are focusing toward the technological advancements in sleep apnea devices such as Fitbit has launched a wearable smartwatch that can help in easy diagnosis of sleep apnea. However, expensive tools used for the treatment of sleep apnea, limited reimbursement of these devices, and low patient compliance are projected to hinder the market growth. Moreover, gradual increase in preference for home healthcare devices is projected to offer lucrative growth opportunities in the near future.

Based on product, the polysomnography (PSG) device generated the highest revenue in 2017 and is expected to maintain this dominance throughout the forecast period. This is attributed to the wide use of these devices in the hospitals and sleep labs, as PSG enables the doctor monitor varied parameters of sleep apnea, such as brain activity, muscle activity, breathing activity, and more to get a comprehensive interpretation of what disorder the patient is suffering from. However, the actigraphy monitoring devices segment is expected to register the highest growth rate during the forecast period, due to its increased use in the homecare settings.

Based on end user, the market is classified into hospitals & sleep laboratories and home care settings. The hospital & sleep laboratories segment dominates the global sleep apnea diagnostics market due to the preference among patients to visit hospitals for the diagnosis of sleep apnea. In addition, sleep labs possess all the different equipment and medical settings required to monitor sleep apnea.

North America was the leading revenue contributor to the global market in 2017, owing to increase in healthcare investments by manufacturers and surge in R&D expenditure for the development of sleep apnea diagnostics. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase in prevalence of sleep apnea owing to the rise in obesity, diabetes, hypertension and other diseases that increases the probability of a person to get suffer from sleep apnea.

Inquiry For Buying@ https://www.alliedmarketresearch.com/purchase-enquiry/4666

Leading Players of the Market:-

• Koninklijke Philips N.V.,
• DeVilbiss Healthcare LLC.,
• Medtronic plc,
• Smiths Medical,
• Mindray,
• Cadwell Laboratories Inc.,
• Natus Medical Incorporated,
• SomnoMedics,
• Nihon Kohden Corporation

Similar Reports:

Antimicrobial Hospital Curtains Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

X-ray photoelectron spectroscopy market – Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Medical Waste Management Market to Thrive on Technological Progress of the Medical and Healthcare Industry, Says TMR

ALBANY, NY, US, September 27, 2021 /EINPresswire.com/ — Medical waste is the waste that come with substances either infectious or potentially infectious and could prove to be hazardous for the human health. It includes waste generated by different healthcare setups, such as dental practices, veterinary clinics, laboratories, medical research facilities, physician’s offices, and hospitals. Medical waste often comes with bodily waste such as blood, bodily fluids, and various other contaminants. It is essential that effective waste management techniques are implemented by these bodies so as to prevent medical waste from harming the environment and human beings. The growing importance of proper disposal of medical waste is likely to bolster expansion of the global medical waste management market over the tenure of assessment.

The development and technological progress of the overall healthcare and medical industry is likely to trigger demand for advanced methods to treat medical waste. Continuous research and development in the healthcare and medical industry are often resulting in various advanced surgical, treatment, and diagnostic solutions. Besides, increased prevalence of various diseases such as chronic disorders and cancer are likely to augur well for the global medical waste management market.

Some prominent players that are operating in the global medical waste management market include names such as BioMedical Waste Solutions, LLC., Sharps Compliance, Inc., ALBA Services GmbH & Co, GRP & Associates, Inc., Republic Services, Inc., and Daniels Sharpsmart Inc.

Request Brochure of Medical Waste Management Market Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2268

According to the TMR report on the global medical waste management market, the market is predicted to grow at a 5% CAGR over the over the forecast period, 2017 to 2025.

Presence of Sound Healthcare System to Drive Market in the North America Region

In terms of region, the global medical waste management market is segmented into the primary regions of Latin America, Asia Pacific, Middle East and Africa, Europe, and North America. Geographical classifications are expected to provide a better understanding of the market dynamics at play at the regional scale.

In the global medical waste management market, North America is expected to emerge as one of the leading regions over the tenure of assessment. The region is likely to observe immense growth owing to the increasing number of patients plagued by different types of infectious and chronic illnesses. Furthermore, the medical waste management market in North America is likely to be shaped by presence of sound healthcare infrastructure and facilities. The US is one of the leading markets in the region and is expected to remain at the forefront of North America market due to the presence of solid healthcare infrastructure.

Request for Analysis of COVID-19 Impact on Medical Waste Management Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2268

Expansion of the Pharmaceutical Industry and Increasing Road Accidents to Augur Well for the Market

Expanding base of geriatric population coupled with rising number of road accidents is expected to leave positive influence on the market over the period of analysis. As such, large amount of waste and byproducts are generated by the availability of advanced medical solutions and expanding pool of patients.

The expansion of the pharmaceutical industry is shaped by the development of various innovative techniques of manufacturing of medical devices and drugs. In addition, efficacious supply of inventories needed in the everyday smooth functioning of clinics, diagnostic centers, and hospitals play an important role in the rapid growth of the global medical waste management market in the forthcoming years. Everyday activities of these setups in the healthcare and medical industry generate huge quantity of waste. These residues and by-products require a proper and effective system or services for the disposal, transportation, gathering, and recycling to avoid and damage to man and nature. This factor is likely to play an important role in the growth of the global medical waste management market over the tenure of assessment, from 2017 to 2025.

Buy Medical Waste Management Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=2268&ltype=S
The information provided in the review has been extracted from a TMR report titled “Medical Waste Management Market (Nature of Waste – Non-hazardous Waste and Hazardous Waste; Waste Type – Sharps, Infectious and Pathological Waste, Radioactive Waste, Pharmaceutical Waste, and Non-infectious Waste; Waste Generator Type – Large Quantity Waste Generators, Mid and Small Quantity Waste Generators; Service Type – On-site Services and Off-Site Services) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025.

Request for Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2268

The Medical Waste Management Market is segmented based on:

Nature of Waste
• Non-hazardous Waste
• Hazardous Waste

Waste Type
• Sharps, Infectious and Pathological Waste
• Radioactive Waste
• Pharmaceutical Waste
• Non-infectious

Waste Generator Type
• Large Quantity Waste Generators
• Mid and Small Quantity Waste Generators

Service Type
• On-site Services
• Off-Site Services

Region
• Latin America
• North America
• Europe
• Japan
• Asia Pacific excluding Japan
• Middle East and Africa

More Trending Reports by Transparency Market Research:

Infection Prevention Devices Market: https://www.transparencymarketresearch.com/infection-prevention-devices-market.html

Sharps Containers Market: https://www.transparencymarketresearch.com/sharps-containers-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Rohit Bhisey
TMR
email us here


Source: EIN Presswire

Digital Pathology Market: Diagnostic Laboratories Segment Hold a Major Share of Global Market

ALBANY, NY, US, September 27, 2021 /EINPresswire.com/ — The global digital pathology market is anticipated to expand at a CAGR of more than 12.0% in the forecast period 2019–2027, states a research report by Transparency Market Research (TMR). The market for digital pathology is projected to reach the valuation of US$ 1.08 Bn by 2027 end.

The study by TMR gives bird’s-eye view of the global digital pathology market. Therefore, readers gain access to key information and assessment on many important aspects shaping the market growth such as expansion opportunities, drivers, challenges, R & D activities, and trends in the market for digital pathology.

In recent period, a rise in the prevalence of various chronic diseases is observed across the globe. This scenario is resulting into increased need for varied advanced therapeutics, and thereby boosting the demand for latest medicines and drugs. As a result, there is significant growth in the number of R & D activities in the healthcare and pharmaceutical industries, which in turn, is anticipated to boost the growth of the global digital pathology market in the years to come.

Request Brochure of Digital Pathology Market Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1540

With notable increase in the number of various exhibitions and trade fairs, there is growth in awareness regarding the advantages of digital pathology solutions. This factor is fueling the expansion opportunities in the digital pathology market.

Digital pathology refers to image-based platform that includes analysis, management, and interpretation of digital information present on a digitized slide. Over the period of past few years, there is significant growth in the use of digital pathology technologies across several application areas including oral pathology, human pathology, and forensic pathology.

Increased use of digital pathology in order to modernize the activities and overall workflow of pathologists and diagnostic laboratories is expected to boost the market growth in the years to come.

Request for Analysis of COVID-19 Impact on Digital Pathology Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1540

Players in Digital Pathology Market Utilize Different Strategic Moves to Expand Their Businesses

F. Hoffmann-La Roche Ltd, OLYMPUS CORPORATION, Leica Biosystems Imaging, Inc, Koninklijke Philips N.V., Mikroscan Technologies, Inc., Inspirata, and Sectra AB are some of the key players working in the global digital pathology market. Thus, the presence of many players signifies highly intense competition in the market.

Leading players in the digital pathology market are growing participation in different strategic moves such as development of technologically advanced products, regulatory approvals, acquisition, launch of new products, and collaborations. These tactics are expected to help enterprises to strengthen their businesses, and thereby boosting the overall growth of the global digital pathology market.

Buy Digital Pathology Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=1540&ltype=S

Players Expected to Gather Promising Expansion Opportunities in North America Market

Europe, Middle East and Africa, Asia Pacific, North America, and Latin America are several important regions for the global digital pathology market. Of them, North America is dominant region of the market for digital pathology.

The North America digital pathology market is projected to witness prominent growth avenues in the upcoming years. Some of the key factors that are likely to help in the market expansion include presence of well-developed healthcare infrastructure, early acceptance of advanced solutions, and large number of patient pool in the region.

Request for Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1540

Global Digital Pathology Market Segmentation

The segmentation of the global digital pathology market is performed on the basis of various key parameters such as product type, applications, end-users, and region. Based on product type, the market for digital pathology is classified into two parts, namely, image analysis software and scanner.
On the basis of end-users, the market for digital pathology is divided into several sections including academic & research centers, diagnostic laboratories, pharmaceutical companies, and others. In terms of applications, the segmentation of digital pathology market is performed into many parts such as consulting services, educational, diagnosis, and others.

The study presented here is based on a report by Transparency Market Research (TMR) titled “Digital Pathology Market (Product Type – Image Analysis Software and Scanners; End use – Diagnostic Laboratories, Academic and Research Centers, Pharmaceutical Companies; Applications – Diagnosis, Consulting Services, Educational) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 – 2027.”

More Trending Reports by Transparency Market Research:

Clinical Laboratory Services Market: https://www.transparencymarketresearch.com/clinical-laboratory-services-market.html

Central Lab Market: https://www.transparencymarketresearch.com/central-lab-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Rohit Bhisey
TMR
email us here


Source: EIN Presswire

Breast Cancer Liquid Biopsy Market Top Companies Analysis To growing at CAGR of 18.3% by 2027

Breast Cancer Liquids Biopsy

Growth of the breast cancer liquid biopsy market is attributed to rise in prevalence of breast cancer across the globe.

PORTLAND, OR, UNITED STATES, September 27, 2021 /EINPresswire.com/ — Breast cancer liquid biopsy provides a real-time method for treatment of breast cancer. It is used for collection & analysis of a blood sample taken from patients. It analyses the presence of tumor cell-derived biomarkers such as circulating tumor cells, extracellular vesicles, and circulating tumor DNA. A breast cancer liquid biopsy is a simple, noninvasive, and cost-effective diagnostic tool for breast cancer. Breast cancer is known to be the second most common malignancy across the globe, therefore, liquid biopsy is a very significant tool for breast cancer diagnosis and determination.

The global breast cancer liquid biopsy market size was valued at $87,641 thousand in 2019, and is projected to reach $336,659 thousand by 2027, registering a CAGR of 18.3% from 2019 to 2027.

Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/7983

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. This COVID-19 pandemic has affected breast cancer liquid biopsy reagent kits production and import & export of raw material and finished goods, owing to shutdowns in various COVID-19-affected countries. Temporary disruptions of inputs or production might stress some companies, particularly those with inadequate liquidity. Moreover, delayed shipments & production schedules create financial problems for companies with heavy debts. This, in turn, has limited the impact of COVID-19 on the breast cancer liquid biopsy market.

The major factors that boosts growth of the breast cancer liquid biopsy market include rise in prevalence of breast cancer, surge in propensity for non-invasive procedures, increase in patient awareness toward breast cancer diagnosis and treatment, intensive R&D in the field of breast cancer, and inclination toward personalized medicine. In addition, technological advancements to detect breast cancer at early stage, rise in demand for better minimally invasive therapies for breast cancer treatment, easy accessibility and high adoption of polymerase chain reaction (PCR) and next-generation sequencing (NGS) among healthcare professionals, and increase in product approvals are also anticipated to drive growth of the market. However, limitations associated with liquid biopsy testing and lack of access and awareness regarding breast cancer liquid biopsy in underdeveloped countries are expected to hinder growth of the market.

The global breast cancer liquid biopsy market is segmented into product & service, circulating biomarker, application, and region. Based on product & service, the market is categorized into reagent kits, instruments, and services. The reagent kits segment dominated the global market in 2019, and is anticipated to continue this trend during the forecast period. Key factors such as advent of novel liquid biopsy reagents that execute circulating biomarker analysis and target enrichment; increase in breast cancer liquid biopsy reagent kits approvals; and increase in funding for breast cancer liquid biopsy R&D are anticipated to drive the growth of the market. In addition, surge in demand for reagent kits, rise in number of breast cancer liquid biopsy test procedures, and increase in prevalence of breast cancer across the globe are other factors that contribute toward growth of the market.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/7983

On the basis of application, the market is classified into diagnostics, prognostics, and risk assessment. The diagnostics segment accounted for maximum market revenue in 2019, and is anticipated to maintain its dominant position during the forecast period, owing to rise in number of patients suffering from breast cancer, rise in trend of developing personalized therapeutics, technological advancements in liquid biopsy systems, and increase in patient awareness toward safe and non-invasive liquid biopsy testing procedures

North America accounted for the largest share of the global breast cancer liquid biopsy market in 2019, and is expected to remain dominant throughout the forecast period. This was attributed to increase in prevalence of breast cancer and higher number of R&D activities to develop novel breast cancer liquid biopsy reagent kits. Moreover, large number of target population with higher health awareness, availability of trained medical professionals, and rise in investments by leading market players and hospitals are other factors that fuel growth of the breast cancer liquid biopsy market.
Asia-Pacific is expected to experience highest growth rate during the forecast period, majorly owing to growth in prevalence of breast cancer and surge in patient awareness toward the use of breast cancer liquid biopsy technique.

Access Full Report @ https://www.alliedmarketresearch.com/breast-cancer-liquid-biopsy-market-A07618

The Major Key Players Are:

Biocept, Inc., F. Hoffmann-La Roche Ltd. (Foundation Medicine, Inc.), Fluxion Biosciences, Inc., Menarini Group (Menarini Silicon Biosystems, Inc.), Myriad Genetics, Inc., NeoGenomics Laboratories, Inc., Qiagen N.V., Sysmex Corporation, and Thermo Fisher Scientific Inc.

Key Findings Of The Study:

• By product & service, the reagent kits segment held largest breast cancer liquid biopsy market share in 2019, and is expected to remain dominant throughout the forecast period.
• On the basis of circulating biomarker, the circulating tumor cell segment held largest market share in 2019, and is expected to remain dominant throughout the forecast period.
• According to application, the diagnostics segment exhibits fastest growth, and is expected to grow at a CAGR of 19.5% from 2019 to 2027.
• Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 20.0% during the forecast period.

Trending Reports In Healthcare Industry:

Non-opioid Pain Patch Market Analysis, Industry Forecast, 2030

Dental Milling Machine Market Analysis, Industry Forecast, 2030

Desiccators Market Analysis, Industry Forecast, 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Kevin McDonnell Named Vice President of Sales at Opeeka

Kevin McDonnell Named Vice President of Sales at Opeeka

Opeeka’s ability to quickly offer person-centered intelligence is a game-changer for service providers and care systems seeking to differentiate and disrupt today.”

— Kevin McDonnell

FOLSOM, CA, UNITED STATES, September 27, 2021 /EINPresswire.com/ — Opeeka, an emerging leader in person-centered behavioral health software solutions, has welcomed Kevin McDonnell as its new Vice President of Global Sales. Kevin joins Opeeka with over 25 years of commercial leadership and management experience in healthcare information technology, including a strong track record of building successful teams in early and growth-stage organizations while driving sales excellence and partner strategies. He also brings deep and broad experience and knowledge in behavioral health, population health, and analytics. Kevin will head up sales strategy, build out the Opeeka sales team, and create and manage relationships with channel sales partners.

Kevin’s appointment comes at a pivotal time for Opeeka as the company accelerates growth in new and existing markets. Kevin’s expertise and leadership will help drive the company’s strategic vision and accelerate its growth, building upon. Moreover, his relationships and business ties with people and organizations throughout the healthcare industry and beyond will accelerate company growth.

“It is a distinct pleasure to welcome Kevin to the Opeeka team,” said Opeeka CMO and Co-founder Ken Knecht. “Kevin’s background in healthcare and technology makes him a perfect addition to our growing team.”

Opeeka launched its Person-Centered Intelligence Solution (P-CIS) in December 2020 and has since experienced rapid growth in the system of care ecosystem serving child welfare, foster care, education, juvenile justice, mental health and behavioral health agencies and organizations.

“Opeeka truly has the most unique and powerful solutions I have seen come on to the market in recent years and I am honored to be a part of the team”, said McDonnell. “I’m joining Opeeka during an exciting time for both the company and our partners and look forward to leveraging my experience to help both achieve massive growth. Opeeka’s ability to quickly offer person-centered intelligence is a game-changer for service providers and care systems seeking to differentiate and disrupt today. I am thrilled to be joining Opeeka and look forward to great things to come.”

About Opeeka

Opeeka’s is a technology company whose products and services enable success-focused care for mental health, behavioral health & social services. Opeeka has identified barriers and constraints in practice and have forged intelligent solutions to help bring clients, family and agencies together to reach positive outcomes more efficiently and effectively. For more information, visit https://www.opeeka.com.

####

Ken Knecht
Opeeka, Inc.
+ +1 916-474-1172
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Success-Focused Care


Source: EIN Presswire

Statement from Joyce Rivera on the Passing and Determination of Death of Actor Michael K. Williams

Joyce Rivera, Founder & CEO, St. Ann's Corner of Harm Reduction

Joyce Rivera, Founder & CEO, St. Ann’s Corner of Harm Reduction

CEO of St. Ann's Corner of Harm Reduction Appeals for Continuance of Harm Reduction and Educational Services

Michael K. Williams was an advocate for neighborhood harm reduction initiatives, claiming about these services that “there is still love and hope in the hood.””

— Joyce Rivera, CEO, St. Ann's Corner of Harm Reduction

NEW YORK, NY, UNITED STATES, September 27, 2021 /EINPresswire.com/ — St. Ann’s Corner of Harm Reduction (www.sachr.org) is deeply saddened by the loss of Michael K. Williams and to learn that the cause of his death was due to a drug overdose, as confirmed by the New York City Medical Examiner on Friday. We knew his struggle and he was real about it. He was an advocate for neighborhood harm reduction initiatives, claiming about these services that “there is still love and hope in the hood.” In loving memory, we will honor his life and all those who have preceded him in similar passing at our inaugural Grace Awards on October 22, 2021. Fa. Luis Barrios , chair of the Board of Directors of SACHR, will lead a tribute to all of the lives that have been lost to overdose. We invite all New Yorkers, family, friends, and colleagues to support the continuance of harm reduction and educational services for all people to avoid the needless loss of loving souls like Michael K. Williams.

About St. Ann’s Corner of Harm Reduction

Founded in 1990 as the first syringe-exchange initiative in the U.S., St. Ann’s Corner of Harm Reduction (SACHR) provides non-judgmental quality access to health resources to persons for whom the social stigma attached to their illicit drug use, HIV/HCV status, poverty, race, gender identity, homelessness, or health undermines their ability to access the services they require or deserve. SACHR meets every person where he or she is, recognizing that people take risks and engage in life-threatening behaviors, therefore it provides a safe haven where participants can consider their personal choices and begin to move toward manageable changes. All services are provided free of charge and anonymously with no demands placed on those who need help. For more information, visit: www.sachr.org.

Roy Cosme
Arcos Communications
+1 212-807-1337
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Michael K. Williams and Curtis Snow Raise Awareness to ATL Harm Reduction


Source: EIN Presswire